Longitudinal Dynamics of Body Weight Change in the Development of Type 2 Diabetes

被引:11
|
作者
Hansen, Barbara C. [1 ,2 ,3 ,4 ]
Newcomb, Jennifer D. [1 ,2 ,3 ]
Chen, Ren [5 ]
Linden, Ellen H. [1 ,2 ,3 ]
机构
[1] Univ S Florida, Coll Med, Obes Diabet & Aging Res Ctr, Tampa, FL 33620 USA
[2] Univ S Florida, Coll Med, Ctr Preclin Res, Tampa, FL USA
[3] Univ S Florida, Coll Med, Dept Internal Med, Tampa, FL 33612 USA
[4] Univ S Florida, Coll Med, Dept Pediat, Tampa, FL 33612 USA
[5] Univ S Florida, Coll Med, Res Off, Tampa, FL USA
关键词
X-RAY ABSORPTIOMETRY; METABOLIC PARAMETERS; RHESUS-MONKEYS; OBESITY; OVERWEIGHT; ADIPOSITY;
D O I
10.1002/oby.20292
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this study was to test the obesity-type 2 diabetes mellitus (T2DM) link in the context of longitudinal changes in body weight during the progression to diabetes in mature adult nonhuman primates (NHP). Design and Methods: A colony of 245 adult rhesus monkeys aged 8-41 years with 179 males were used to define overweight in males as a body weight: >= 13.5 kg or body fat (BF) >= 18% and obesity as >= 16.5 kg or BF >= 27%, and overweight in nonpregnant females was identified as a body weight >8.5 kg or BF >21% and obesity as >= 10.5 kg or BF >= 30%. A subgroup of 48 males (24 T2DM and 24 age-matched non-T2DM) males were studied before and following the onset of overt T2DM for the effects of changes in body weight and obesity in inducing this conversion to overt T2DM. Results: Three years before overt T2DM, mean body weight was 18.4 +/- 3.3 kg. The DM-destined group body weight was 3.2 +/- 1.1 kg greater and had a longer duration and greater severity of obesity, with peak body weight reached at 3.2 +/- 1.8 years before overt T2DM. At DM onset the two groups did not differ significantly in body weight or adiposity. Conclusions: The natural progression from pre-DM to overt T2DM is caused neither by the amount of excess body weight at DM onset nor by the proximate increases in body weight/adiposity during the pre-DM period of impaired glucose tolerance. Obesity was, however, essential preceding all NHP cases that developed T2DM.
引用
收藏
页码:1643 / 1649
页数:7
相关论文
共 50 条
  • [1] Body Weight Change and Type 2 Diabetes
    Kodama, Satoru
    Horikawa, Chika
    Yoshizawa, Sakiko
    Fujihara, Kazuya
    Yachi, Yoko
    Tanaka, Shiro
    Suzuki, Akiko
    Hanyu, Osamu
    Yagyu, Hiroaki
    Sone, Hirohito
    EPIDEMIOLOGY, 2013, 24 (05) : 778 - 779
  • [2] Stability of body weight in type 2 diabetes
    Chaudhry, ZW
    Gannon, MC
    Nuttall, FQ
    DIABETES CARE, 2006, 29 (03) : 493 - 497
  • [3] Stability of body weight in type 2 diabetes
    Craudhry, Z
    Gannon, MC
    Nuttall, FQ
    DIABETES, 2005, 54 : A427 - A427
  • [4] Weight change patterns in type 2 diabetes
    Tuthill, A
    Curran, S
    McKenna, M
    O'Shea, D
    McKenna, T
    DIABETES, 2003, 52 : A560 - A560
  • [5] Body Mass Index, Change in Weight, Body Weight Variability and Outcomes in Type 2 Diabetes Mellitus (from the ACCORD Trial)
    Yeboah, Phyllis
    Hsu, Fang-Chi
    Bertoni, Alain G.
    Yeboah, Joseph
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (04): : 576 - 581
  • [6] Lack of Association of Type 2 Diabetes Susceptibility Genotypes and Body Weight on the Development of Islet Autoimmunity and Type 1 Diabetes
    Winkler, Christiane
    Raab, Jennifer
    Grallert, Harald
    Ziegler, Anette-Gabriele
    PLOS ONE, 2012, 7 (04):
  • [7] Body Weight Considerations in the Management of Type 2 Diabetes
    Apovian, Caroline M.
    Okemah, Jennifer
    O'Neil, Patrick M.
    ADVANCES IN THERAPY, 2019, 36 (01) : 44 - 58
  • [8] SURMOUNTing body weight barriers in type 2 diabetes
    Novikoff, Aaron
    Mueller, Timo D.
    MED, 2023, 4 (12): : 849 - 851
  • [9] Body Weight Considerations in the Management of Type 2 Diabetes
    Caroline M. Apovian
    Jennifer Okemah
    Patrick M. O’Neil
    Advances in Therapy, 2019, 36 : 44 - 58
  • [10] Changes in Body Mass Index and weight before and after the development of type 2 diabetes
    Looker, HC
    Knowler, WC
    Hanson, RL
    DIABETES, 2001, 50 : A534 - A534